Caffeine Completed Phase 1 Trials for Tumors, Solid Other
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Other | 1 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT01517399 | Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects |